Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
Last week, researchers, academics, doctors and advocates from all over the world gathered in Mexico City, Mexico at the 13th International Congress of Parasitology (ICOPA). Sabin Vaccine Institute (Sabin) President Dr.
The accomplishments and work of Sabin and its three major programs — Vaccine Advocacy & Education, the Sabin Product Development Partnership (Sabin PDP) and the Global Network for Neglected Tropical Diseases (Global Network) — are highlighted in our 2013 Annual Report.